Literature DB >> 10474476

Transfer of a pedicled venous flap containing perivenous areolar tissue and nerve: an experimental study.

K Murata1, S Tamai, Y Inada, A Fukui, S Miyamoto.   

Abstract

In this paper, we evaluated experimentally the feasibility of transferring a pedicled venous flap with perivenous areolar tissue into an ectopic site and investigated the role of each vein, the perivenous areolar tissue and nerve in the viability of pedicled venous flaps. Three groups of flaps were created using a rabbit-ear model: Group 1 (n = 11), containing perivenous areolar tissue and a draining vein; Group 2 (n = 10), perivenous areolar tissue, a draining vein and nerve; Group 3 (n = 10), only perivenous areolar tissue. Macroscopic, angiographic and histological assessments were performed 14 days after transfer. The total survival areas including superficial necrosis of Groups 1, 2 and 3 were 52.7%, 82.5% and 0%, respectively. There were significant differences in mean survival area and mean total survival area including superficial necrosis between Group 1 and Group 2 (P < 0.05). In contrast, all flaps in Group 3 became necrotic. These data suggest that a preserved vein is the necessary condition, and additional arterial flow through the preserved nerve and a small vascular network within the areolar tissue may play an important role in flap survival.

Entities:  

Mesh:

Year:  1999        PMID: 10474476     DOI: 10.1054/bjps.1997.3039

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  2 in total

1.  Distally based venous flap: a new technique for the correction of syndactyly without skin graft in adult patients.

Authors:  Yakup Cil; Atacan Emre Kocman; Abdul Kerim Yapici
Journal:  Chir Organi Mov       Date:  2009-10-30

2.  Unconventional Perfusion Flaps in the Experimental Setting: A Systematic Review and Meta-Analysis.

Authors:  Diogo Casal; David Tanganho; Teresa Cunha; Eduarda Mota-Silva; Inês Iria; Diogo Pais; Paula Videira; José Videira-Castro; João Goyri-O'Neill
Journal:  Plast Reconstr Surg       Date:  2019-05       Impact factor: 4.730

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.